Garde Capital’s MetLife MET Stock Holding History

Garde Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-150	Closed	-$12.1K	–	578
2025 Q2	$12.1K	Buy	+150	New	+$11.6K	﹤0.01%	493
2023 Q3	–	Sell	-8,140	Closed	-$460K	–	271
2023 Q2	$460K	Buy	+8,140	New	+$452K	0.04%	147

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Garde Capital's MET Position: Q3 2025 in Review

Garde Capital sold out of MetLife (MET) in Q3 2025, closing a stake of 150 shares — an estimated $12.1K sold.

Garde Capital first reported a position in MET in Q2 2023 and held it in 2 quarters. The position peaked at $460K in Q2 2023. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.

Garde Capital reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 150 MetLife shares in Q3 2025, an estimated $12.1K.
Garde Capital first reported a position in MetLife in Q2 2023 and held it in 2 quarters.
Garde Capital's MetLife position peaked at $460K in Q2 2023.
1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.